Burden of MenopauseProviding women with information about HRT can help when making decisions about the treatment options they would prefer. You can also discuss the impact of their symptoms. Healthcare professionals have a key role in the management of the menopause.
Oestrogel (estradiol) is an oestrogen-only treatment indicated for:15
Hormone replacement therapy (HRT) for oestrogen deficiency symptoms in postmenopausal women
Prevention of osteoporosis in postmenopausal women at high risk of future fractures who are intolerant of, or contraindicated for, other medicinal products approved for the prevention of osteoporosis
The experience treating women older than 65 years is limited
Oestrogel
is a clear colourless oestrogen gel15
is a body identical transdermal gel containing 17β-estradiol2, 15
is identical to the oestrogen produced by the body2, 15
is the number one selling transdermal oestrogen gel in Europe and UK16
Imvaggis is indicated for the local treatment of vaginal symptoms of oestrogen deficiency in postmenopausal women9
An ultra-low dose, estriol pessary that is easily inserted without the need for an applicator, designed with the patient in mind9, 10
Imvaggis significantly improves the symptoms of vaginal atrophy vs placebo at 12 weeks (p<0.001)11
The estriol (active ingredient) in Imvaggis is body identical, it is derived from yams and soya and is chemically identical to estriol produced naturally by the body 2, 9, 12
Imvaggis aligns with recommendations to use the lowest effective dose for treatment of vaginal atrophy13